Contact information
Type
Scientific
Primary contact
Mr Malcolm Doupe
ORCID ID
Contact details
Primary Health Care Research Unit
St Boniface Research Centre
Winnipeg
Manitoba
R2H 2A6
Canada
mdoupe@sbrc.ca
Additional identifiers
EudraCT number
ClinicalTrials.gov number
Protocol/serial number
N/A
Study information
Scientific title
Acronym
MAAUI
Study hypothesis
Not provided at time of registration
Ethics approval
Not provided at time of registration
Study design
Randomised controlled trial
Primary study design
Interventional
Secondary study design
Randomised controlled trial
Trial setting
GP practices
Trial type
Quality of life
Patient information sheet
Condition
Chronic pain
Intervention
All primary care physicians in Manitoba, Canada have been randomly assigned to a control group or an intervention study group. The educational intervention being evaluated consists of an audit and feedback mechanism combined with optional participation in a Continuing Medical Education interactive workshop. The primary outcome of the study is the change, from pre- to post- intervention, in physicians' appropriate prescribing of non-steroidal anti-inflammatory therapies for patients requiring chronic treatment. Three classes of non-steroidal anti-inflammatory therapies have been identified: a new class of non-steroidal anti-inflammatory agents known as coxib therapy, traditional non-steroidal anti-inflammatory drug (NSAID) monotherapy, and traditional NSAID therapy combined with gastro-protective agents. Appropriate prescribing is defined based on international clinical practice guidelines and the provincial drug reimbursement policy in Manitoba.
Intervention type
Other
Phase
Not Specified
Drug names
Primary outcome measures
Not provided at time of registration
Secondary outcome measures
Not provided at time of registration
Overall trial start date
01/11/2000
Overall trial end date
01/01/2004
Reason abandoned
Eligibility
Participant inclusion criteria
All primary care physicians in Manitoba, Canada
Participant type
Patient
Age group
Not Specified
Gender
Not Specified
Target number of participants
Not provided at time of registration
Participant exclusion criteria
Not provided at time of registration
Recruitment start date
01/11/2000
Recruitment end date
01/01/2004
Locations
Countries of recruitment
Canada
Trial participating centre
Primary Health Care Research Unit
Winnipeg, Manitoba
R2H 2A6
Canada
Sponsor information
Organisation
Merck Frosst Canada and Co. (Canada)
Sponsor details
C.P. 1005
Pointe-Claire-Dorval
Quebec
H9R 4P8
Canada
lorijean_manness@merck.com
Sponsor type
Industry
Website
Funders
Funder type
Industry
Funder name
Merck Frosst Canada Ltd (Canada)
Alternative name(s)
Funding Body Type
Funding Body Subtype
Location
Results and Publications
Publication and dissemination plan
Not provided at time of registration
Intention to publish date
Participant level data
Not provided at time of registration
Results - basic reporting
Publication summary
Protocol in: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15327694
Publication citations
-
Protocol
Doupe M, Katz A, Kvern B, Manness LJ, Metge C, Thomson GT, Morrison L, Rother K, Encouraging physician appropriate prescribing of non-steroidal anti-inflammatory therapies: protocol of a randomized controlled trial [ISRCTN43532635]., BMC Health Serv Res, 2004, 4, 1, 21, doi: 10.1186/1472-6963-4-21.